Patent · US Active

Itraconazole analogs and use thereof

US11028078B2 · kind B2 · utility

0Cited by
2References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 4, 2018
Grant dateJun 8, 2021
Priority date
Expiry dateOct 4, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/506
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are Itraconazole analogs. Also provided herein are methods of inhibition of Hedgehog pathway, vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, angiogenesis and treatment of disease with Itraconazole analogs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.